SCHEMBL14033908

SCHEMBL14033908

CC[C@H]1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CCN1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.54
CYP19A1 P11511 1/20 0.54
OPRM1 P35372 2/20 0.46
OPRD1 P41143 1/20 0.46
SLC6A9 P48067 3/20 0.46
SLC6A2 P23975 7/20 0.42
SLC6A4 P31645 7/20 0.42
SLC6A3 Q01959 7/20 0.42
CHRM2 P08172 2/20 0.42
HTR1A P08908 2/20 0.42
ADRA2A P08913 2/20 0.42
CHRM1 P11229 2/20 0.42
DRD1 P21728 2/20 0.42
TBXA2R P21731 2/20 0.42
ADRA1A P35348 2/20 0.42
DRD3 P35462 2/20 0.42
KCNH2 Q12809 2/20 0.42
BCL2 P10415 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14033868 0.87 CYP2D6 (0.49) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL26673752 0.86 HRH3 (0.46) CYP2D6CYP19A1OPRM1OPRD1SLC6A2
SCHEMBL14034041 0.83 CYP2D6 (0.48) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL26955676 0.82 CYP2D6 (0.60) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL14033816 0.78 CYP2D6 (0.55) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL14034022 0.78 CYP2D6 (0.55) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL6829324 0.78 SLC6A9 (0.51) CYP2D6CYP19A1OPRD1SLC6A9SLC6A2
SCHEMBL14034069 0.77 CYP2D6 (0.54) CYP2D6CYP19A1OPRM1OPRD1SLC6A9
SCHEMBL6582183 0.76 CYP2D6 (0.43) CYP2D6CYP19A1OPRM1SLC6A2SLC6A4
SCHEMBL14033507 0.75 CYP2D6 (0.51) CYP2D6CYP19A1OPRM1OPRD1SLC6A9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed